Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript
Viatris Inc. misses on earnings expectations. Reported EPS is $0.09417 EPS, expectations were $0.68.
Viatris Inc (VTRS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 21,395,052 | $255,456,921 | +8% | 4.44% |
| 2. | Rubric Capital Management David Rosen | 18,442,093 | $220,198,590 | +5% | 6.5% |
| 3. | Slate Path Capital David Greenspan | 10,798,000 | $128,928,120 | -30% | 2.55% |
| 4. | Glenview Capital Larry Robbins | 5,141,999 | $61,395,468 | -16% | 1.07% |
| 5. | AQR Capital Management Cliff Asness | 4,949,235 | $58,772,163 | -45% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.90 | 2,700 | Director | 22,031 | 2022-03-15 | Filing | |
| $9.87 | 50,352 | Officer, Director | 136,796 | 2022-03-15 | Filing | |
| $15.45 | 500 | Director | 5,000 | 2021-05-21 | Filing | |
| $15.79 | 1,500 | Director | 4,500 | 2021-05-19 | Filing | |
| $13.84 | 3,000 | Director | 3,000 | 2021-03-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.18 | 264,300 | 645,519 | 2024-06-14 | Filing | ||
| $10.52 | 85,660 | 909,819 | 2024-06-13 | Filing | ||
| $10.38 | 89,419 | 67,723 | 2024-05-28 | Filing | ||
| $12.09 | 250,000 | 243,044 | 2024-03-13 | Filing | ||
| $12.33 | 24,353 | 153,826 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 142,263,858 | $1,540,717,582 | 0.03% | |
| 2. | 92,337,568 | $1,000,015,864 | 0.02% | |
| 3. | 62,661,728 | $678,626,527 | 3.83% | |
| 4. | 61,923,920 | $670,636,054 | 0.03% | |
| 5. | 30,143,488 | $326,453,976 | 0.07% |
News See All
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Bill Miller's Latest 13 Stock Picks
In this piece, we will take a look at Bill Miller's latest stock picks.
5 Best Dividend-Paying Stocks Under $15
In this article, we discuss 5 best dividend-paying stocks under $15.
Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript
Viatris Inc. misses on earnings expectations. Reported EPS is $0.61 EPS, expectations were $0.67. Viatris Inc.
13 Best Pharma Dividend Stocks To Buy in 2024
In this article, we discuss 13 best pharma dividend stocks to buy in 2024.
Here’s Why Greenlight Decided to Repurchase Viatris (VTRS)
Greenlight Capital, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here.
12 S&P 500 Stocks On the Move
The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.
5 Best Low-Priced Dividend Stocks To Invest In
In this policy review – we will maintain important aspects that will guarantee the financial soundness of the company, the control of that.
Billionaire Hedge Funds
